Atea Pharmaceuticals Inc expected to post earnings of 17  cents a share - Earnings Preview

Atea Pharmaceuticals

25/02/2022 22:56

* Atea Pharmaceuticals Inc  AVIR.OQ   AVIR.O  is expected
to show
a rise in quarterly revenue when it reports  results on February
28. 
    * The Boston Massachusetts-based  company is expected to
report  a
76.3% increase in revenue to $85.727 million from $48.63 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Atea
Pharmaceuticals Inc
is for earnings of 17 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Atea
Pharmaceuticals Inc is $8​, about 22.3% above​ its last closing
price of $6.22. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.12       -0.05      -0.34     Missed  -547.6
 Jun. 30 2021  -0.10       0.01       0.02      Beat    300
 Mar. 31 2021  -0.10       -0.05      0.34      Beat    718.2​
 Dec. 31 2020              0.16                         
 ​​Sep.        -1.05       -1.05      -1.74     Missed  -64.9
 30 2020                                                
                                                        ​
 This summary was machine generated February 25 at 22:56 GMT. 
All figures in US dollars  unless otherwise stated